Dry Eye Disease Diagnostic Devices Market 2031 - TMR Detailed Analysis Report

U.S. Dry Eye Disease Diagnostic Devices Market: Introduction

According to the report, the dry eye disease diagnostic devices market in the U.S. was valued at US$ 58.3 Mn in 2020 and is projected to expand at CAGR of 4.4% from 2021 to 2031. Dry eye disease diagnostic devices include anterior segment OCT (AS-OCT), meibography device, corneal topographer, and osmolarity testing device. The usage of dry eye disease diagnostic devices can be classified based on the parameter measured into tear film osmolarity, tear turnover, functional visual acuity, tear volume, tear film stability, tear film composition, ocular biomarkers, and others.

Get Sample Copy of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=84250

Rise in Prevalence and Incidence Rates of Dry Eye Disease in U.S.

In the U.S., dry eye disease is considered a critical and significant public health issue. An article published in the American Journal of Ophthalmology stated that the overall estimated prevalence of dry eye disease was 5.28% in the U.S. between 2003 and 2015. It also indicated that the prevalence and incidence vary from 5% to 50%, and it is rising due to higher incidence of some risk factors and gradual increase in the geriatric population. Hence, rise in prevalence of dry eye disease is anticipated to drive the market.

Rise in prevalence and incidence rates of dry eye disease and surge in geriatric population increase the risk of dry eye diseases in the U.S., which, in turn, augments the market in the country.

Get Custom Research Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=84250

Meibography Device Segment to Lead U.S. Dry Eye Disease Diagnostic Devices Market

In terms of device type, the dry eye disease diagnostic devices market in the U.S. has been classified into meibography device, corneal topographer, anterior segment OCT (AS-OCT), osmolarity testing device, ocular surface thermographer, interferometer, fluorophotometer, and others. The meibography device segment is expected to account for major share of the market in the U.S. in 2031. The segment is likely to expand at a CAGR of 3.8% during the forecast period. Meibomian gland disease is considered the primary cause of evaporative dry eye disease. This drives usage of meibography devices in the diagnosis of dry eye.

Read Report Overview @ https://www.transparencymarketresearch.com/us-dry-eye-disease-diagnostic-devices-market.html

Diagnostic Centers to be Key End-user

Based on end-user, the dry eye disease diagnostic devices market in the U.S. has been divided into hospitals, diagnostic centers, ophthalmology centers/clinics, and others. The diagnostic centers segment is projected to account for major share of the market in the U.S. in 2031. The segment is anticipated to expand at a CAGR of 4.5% from 2021 to 2031. Rise in prevalence of dry eye disease in the U.S., increase in ophthalmology group practice, multi-subspecialty group, single-subspecialty group, and surge in frequency of patients for diagnosis of dry eye disease in these centers propel the segment.

Competition Landscape

Key players operating in the dry eye disease diagnostic devices market in the U.S. include Johnson & Johnson Services, Inc., OCULUS Optikgeräte GmbH, Carl Zeiss Meditec AG, TearLab Corporation, Optovue, Inc., AXIM Biotechnologies, Topcon Corporation, Quantel Medical, Essilor Instruments, I-MED Pharma, Inc., Box Medical Solutions, Inc., and NIDEK CO., LTD.

Enquiry before Buying @ https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=84250

U.S. Dry Eye Disease Diagnostic Devices Market: Segmentation

U.S. Dry Eye Disease Diagnostic Devices Market, by Device Type

Anterior Segment OCT (AS-OCT)
Meibography Device
Corneal Topographer
Osmolarity Testing Device
Ocular Surface Thermographer
Interferometer
Fluorophotometer
Others

U.S. Dry Eye Disease Diagnostic Devices Market, by Disease

Evaporative Dry Eye Syndrome
Aqueous Dry Eye Syndrome

Ask References @ https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=84250

U.S. Dry Eye Disease Diagnostic Devices Market, by End-user

Hospitals
Diagnostic Centers
Ophthalmology Centers/Clinics
Others

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

This release was published on openPR.